Recent studies into retatruptide peptide reveal promising possibility for managing excess body and type disease. The molecule, a dual stimulator of GLP-1 receptor and GIP receptor, looks to provide improved body mass and glycemic regulation in contrast to existing therapies. Ongoing research effo